Vanguard Group
MDLN

Vanguard Group’s Medline Inc MDLN Stock Holding History

Vanguard Group’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$793M Buy
+18,887,568
New +$798M 0.01% 817

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group's MDLN Position: Q4 2025 in Review

Vanguard Group opened a new position in Medline Inc (MDLN) in Q4 2025: 18,887,568 shares worth $793M. The stake represents 0.01% of the portfolio and ranks #817 among its holdings.

205 funds tracked by Wall St. Rank hold MDLN as of Q4 2025.

  • Vanguard Group held 18,887,568 shares of Medline Inc worth $793M as of Q4 2025.
  • Medline Inc was a new Vanguard Group position in Q4 2025.
  • Medline Inc made up 0.01% of Vanguard Group's portfolio in Q4 2025, its #817 holding.
  • 205 funds tracked by Wall St. Rank held Medline Inc as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.